Detalhe da pesquisa
1.
Three cooperative mechanisms required for recovery after brain damage.
Sci Rep
; 9(1): 15858, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31676810
2.
Vitamin D receptor polymorphisms as tool for early screening of severe bone loss in women patients with rheumatoid arthritis.
Eur Rev Med Pharmacol Sci
; 20(22): 4664-4669, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27906437
3.
Antioxidant diet and genotyping as tools for the prevention of liver disease.
Eur Rev Med Pharmacol Sci
; 20(24): 5155-5163, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28051253
4.
Quantitative PCR detection of t(11;14) bcl-1/JH in mantle cell lymphoma patients: comparison of peripheral blood and bone marrow aspirate samples.
Eur Rev Med Pharmacol Sci
; 19(24): 4801-10, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26744872
5.
Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: a two-stage phase 2 study.
Oncology
; 58(1): 8-14, 2000.
Artigo
em Inglês
| MEDLINE | ID: mdl-10644934
6.
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study).
Br J Cancer
; 71(6): 1283-7, 1995 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-7779724
7.
The prognostic value of lymphatic and blood vessel invasion in operable breast cancer.
Cancer
; 76(10): 1772-8, 1995 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-8625046
8.
A phase I study of paclitaxel and epirubicin, without and with filgrastim, for the treatment of platinum-resistant advanced ovarian cancer.
Oncology
; 56(4): 267-73, 1999.
Artigo
em Inglês
| MEDLINE | ID: mdl-10343189
9.
A phase I study of gemcitabine and epirubicin for the treatment of platinum-resistant or refractory advanced ovarian cancer.
Ann Oncol
; 11(5): 613-6, 2000 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-10907958